These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 28675068)
1. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study. Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068 [TBL] [Abstract][Full Text] [Related]
2. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography. Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523 [TBL] [Abstract][Full Text] [Related]
3. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085 [TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692 [TBL] [Abstract][Full Text] [Related]
5. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse. Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363 [TBL] [Abstract][Full Text] [Related]
6. Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy. Kawashima K; Ishihara S; Yuki T; Fukuba N; Sonoyama H; Kazumori H; Yamashita N; Tada Y; Kusunoki R; Oka A; Oshima N; Mishima Y; Moriyama I; Kinoshita Y Inflamm Bowel Dis; 2017 Nov; 23(11):2027-2034. PubMed ID: 28817462 [TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660 [TBL] [Abstract][Full Text] [Related]
9. Serum calprotectin as a biomarker for Crohn's disease. Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E; J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231 [TBL] [Abstract][Full Text] [Related]
10. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670 [TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease. Naismith GD; Smith LA; Barry SJ; Munro JI; Laird S; Rankin K; Morris AJ; Winter JW; Gaya DR J Crohns Colitis; 2014 Sep; 8(9):1022-9. PubMed ID: 24566170 [TBL] [Abstract][Full Text] [Related]
12. Low fecal calprotectin predicts clinical remission in Crohn's disease patients: the simple answer to a challenging question. Monteiro S; Dias de Castro F; Leite S; Moreira MJ; Cotter J Scand J Gastroenterol; 2019 Jan; 54(1):49-54. PubMed ID: 30663515 [TBL] [Abstract][Full Text] [Related]
13. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients. Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509 [TBL] [Abstract][Full Text] [Related]
14. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy. Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986 [TBL] [Abstract][Full Text] [Related]
15. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease. Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408 [TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969 [TBL] [Abstract][Full Text] [Related]
17. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin. Zubin G; Peter L Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564 [TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease. Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822 [TBL] [Abstract][Full Text] [Related]
19. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease. Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy. Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]